Connect with us

Hi, what are you looking for?

Economy

House Pentagon funding bill would ban transgender treatments for minor children of military personnel

The GOP-controlled House of Representatives passed its annual defense spending bill Wednesday, including a key culture-war caveat: a ban on transgender medical treatments for minor children of U.S. service members.

The provision in the 1,800-page bill states that ‘medical interventions for the treatment of gender dysphoria that could result in sterilization may not be provided to a child under the age of 18,’ referring to the transgender children of military personnel. 

Republicans argued that taxpayer dollars should not fund potentially experimental and harmful procedures for minors.

House Speaker Rep. Mike Johnson, R-La., praised the passage of the defense measure, though it now heads to the Senate for approval in the Democrat-run chamber.

‘Our men and women in uniform should know their first obligation is protecting our nation, not woke ideology,’ Johnson said in a statement after the measure passed.

While the provision was a win for Republicans that could further push President-Elect Donald Trump’s policy agenda, the measure did not incorporate several other Republican-backed provisions related to social issues. Notably absent were efforts to ban TRICARE, the military’s health program, from covering transgender treatments for adults and a proposal to overturn the Pentagon’s hotly-debated policy of reimbursing travel expenses for service members seeking abortions stationed in states where the procedure is restricted.

Democrats were largely outraged by the provision to strip TRICARE from service members’ transgender children, with the House Armed Services Committee’s top Democrat, Rep. Adam Smith, vowing to vote against the bill on Tuesday despite helping on other portions of the package. Meanwhile, House Minority Leader Rep. Hakeem Jeffries, D-N.Y., did not advise his party members to vote for or against it.

The measure also drew the ire of the United Nations’ Human Rights Council (HRC), which called it an ‘attack’ on military families.

‘This cruel and hateful bill suddenly strips away access to medical care for families that members of our armed forces are counting on, and it could force service members to choose between staying in the military or providing health care for their children,’ HRC President Kelley Robinson said in a statement.

The Senate’s response to the transgender treatment provision will be pivotal in determining the final content of the defense policy for the upcoming fiscal year. If it passes, it would align with Trump’s criticisms of the military’s ‘woke’ policies. 

The Supreme Court also heard oral arguments last week for a first-of-its-kind case involving Tennessee’s ban on transgender medical procedures for minors, which could place further restrictions on the procedures.

The $884 billion National Defense Authorization Act, which sets policies for the Defense Department, was passed in a 281-140 vote, with 124 Democrats and 16 Republicans voting against it. 

Other provisions also place limits on diversity, equity and inclusion-based recruitment and the teaching of critical race theory in military-run schools. Other policies include a 14.5% pay boost for junior enlisted troops, expanded child care access and enhanced job assistance for military spouses, reflecting a year of bipartisan focus on addressing record recruitment struggles.

Fox News Digital’s Elizabeth Elkind contributed to this report.

This post appeared first on FOX NEWS

World biggest companies

Learn Trading With Online Courses, Classes, & Lessons

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2024 GreatWallStreetPublisher.com